April 16, 2015
The relatively recent proliferation of publicly traded patent assertion entities (PAEs) has cast some light on the ways in which PAEs seek to earn revenue based on their primary factors of production—capital and patents. Our RPX Q4 2014 Public PAE Report provides summary statistics for a variety of metrics relevant to the public market.
Read more
March 12, 2015
Our 2014 NPE Litigation Report—a continuation of our effort to provide a uniquely clear and quantitative picture of NPE patent litigation—includes updated data on the domination of NPEs in patent litigation, the impact of NPEs on smaller companies, and other emerging trends.
Read more
December 2, 2014
A comprehensive look at how thousands of portfolios have transacted on the open market since 2008. Analysis shows companies have achieved $1B+ in cost savings by preemptively buying patents offered on the open market versus later engaging in litigation.
Read more